HomeSearchCancer Chemotherapy and Pharmacology

Cancer Chemotherapy and Pharmacology

Springer Science and Business Media Deutschland GmbH · Germany · Est. 1977

ISSN1432-0843
SJR Q2WOS SCIEScopus / SJR
Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

📊 Standing in its field
Where this journal ranks among others in the same subject area.
Q2
SJR · Scopus
Top 50% in field
Clarivate’s JCR quartile is a separate ranking and may differ
SJR Scorei
0.851
H-Indexi
153
SNIPi
0.787
Total Worksi
9,829
Total Citationsi
273,142
2yr Mean Citednessi
1.95
Open Impact Factor alternative
Retractions
16
Source: Retraction Watch

Aims & Scope

Cancer Chemotherapy and Pharmacology reports preclinical and or clinical pharmacology of anticancer drugs, covering pharmacokinetics and pharmacodynamics aspects. The journal publishes results recorded in the following areas: - Pharmacokinetics - Pharmacodynamics - Drug interactions - Exposure response relationships - Predictors of response/toxicity

General Information

Country / RegionGermany
Primary LanguageEnglish
1st Year Published1977
FrequencyMonthly
StatusActive (last: 2026)
Total Publications9,829
Publisher OrgSpringer Science+Business Media
Visit Journal Website

Submission Info

Peer Review
OA License
OA Rate

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

6/11 · 55%
Do you know the journal / publisher?
Springer Science and Business Media Deutschland GmbH
Does the journal have a website?
✓ Linked
Is the ISSN verified?
1432-0843
Indexed in a trusted database?
WoS, Scopus
Peer review process documented?
N/A
Follows ethical publishing standards (COPE)?
N/A
Not on predatory/blacklists?
✓ Clean
Long-term digital preservation?
N/A
Plagiarism detection in place?
N/A
Listed in DOAJ (verified OA)?
N/A
Primary language documented?
English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
252
5.7k
2019
184
3.2k
2020
173
2.7k
2021
125
1.3k
2022
126
989
2023
109
452
2024
112
224
2025
93
33
2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

OncologyQ2
PharmacologyQ2
Pharmacology (medical)Q2
ToxicologyQ2
Cancer ResearchQ3

Subject Classification

Web of Science Categories

OncologyPharmacology & Pharmacy

Scopus Categories

PharmacologyPharmacology (medical)Cancer ResearchOncologyToxicology

Research Topics (OpenAlex)

Cancer Treatment and PharmacologyCancer therapeutics and mechanismsColorectal Cancer Treatments and StudiesLung Cancer Research StudiesLung Cancer Treatments and MutationsChemotherapy-induced organ toxicity mitigationDrug Transport and Resistance MechanismsChemotherapy-induced cardiotoxicity and mitigationAcute Lymphoblastic Leukemia researchHER2/EGFR in Cancer Research

Frequently asked questions about Cancer Chemotherapy and Pharmacology

Is Cancer Chemotherapy and Pharmacology a predatory journal?

PubScope has no integrity flags on record for Cancer Chemotherapy and Pharmacology: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Cancer Chemotherapy and Pharmacology?

Cancer Chemotherapy and Pharmacology is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.95.

Is Cancer Chemotherapy and Pharmacology indexed in Scopus and Web of Science?

Cancer Chemotherapy and Pharmacology is indexed in Web of Science, Scopus.

What is the aims and scope of Cancer Chemotherapy and Pharmacology?

Cancer Chemotherapy and Pharmacology reports preclinical and or clinical pharmacology of anticancer drugs, covering pharmacokinetics and pharmacodynamics aspects. The journal publishes results recorded in the following areas: - Pharmacokinetics - Pharmacodynamics - Drug interactions - Exposure response relationships - Predictors of response/toxicity

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref